Scientific Program





Live Stream from Berlin – in Tv Quality

Chat Window: Discuss with us! Send us your questions and comments!

  • Presidential Lectures
  • Scientific Lectures
  • Pro/Con Debates
  • State of the Art Sessions
  • Educational Sessions
  • CMC Panel Discussions
  • Symposia

Part I: Breast Cancer

icon berlin time webModeration: J.-U. Blohmer (Berlin)
Co-Moderation: M. P. Goetz (online)
09:00 – 09:05 am
Welcome and Introduction
J. Sehouli, J.-U. Blohmer
09:05 – 09:45 am

Presidential Lectures

New ER-targeted Therapies: SERDs, SERMs, PROTACs and SERCAs
M. P. Goetz
Practice-changing Study Results of Breast Surgery and Reconstruction
J.-U. Blohmer

09:45 – 10:15 am

Satellite Symposium with kind support of AstraZeneca

Targeting Future Perspectives in Clinical Oncology
Chairs: J. Sehouli, J.-U. Blohmer

  • Strategies to Overcome Endocrine Resistance in Breast Cancer
    J.-U. Blohmer
  • Combining Immunotherapy and PARP Inhibition in Gynecological Cancer
    J. Sehouli
10:15 – 10:35 am

State of the Art Session

Chairs: M. P. Goetz, O. Camara

HER2-positive Breast Cancer: Which Therapies When and for Whom?
J. K. Wagner

TNBC and Immune Checkpoint Therapies: Do We Have Predictive Factors for High Benefit?
V. Kiver

10:35 – 11:05 am

Satellite Symposium with kind support of Daiichi Sankyo

The Future Starts Today: ADCs in Breast and Women’s Cancer
Chairs: J. Sehouli, J.-U. Blohmer

  • Spotlight Metastatic Breast Cancer: Established and New Treatment Options
    J.-U. Blohmer
  • Rising Stars: ADCs in Gynaecological Tumors
    J. Sehouli
  • Hotchair: Panel Discussion – What are the Learnings from Breast to Women’s Cancer?
    J.-U. Blohmer, J. Sehouli
11:05 – 12:25 am

Scientific Lectures

Chairs: J. K. Wagner, V. Kiver

Immune Checkpoint Therapies for ER+ Breast Cancer: New Evidence
K. Giridhar

Is Chemotherapy for Early ER+ Breast Cancer Patients Still Necessary?
S. Kümmel

Identification and Selection of Patients for Genetic Testing
S. Yadav

Hormone Replacement Therapy: Newer Evidence
S. Pruthi

12:25 – 12:40 am

Part II: Ovarian Cancer

icon berlin time webChairs: E. I. Braicu, J. Sehouli (Berlin)
Co-Chairs: W. Cliby, A. Wahner-Hendrickson (online)
12:40 – 01:00 pm

Presidential Lecture

Ovarian Cancer Management: Yesterday, Today, Tomorrow
J. Ledermann

01:00 – 01:20 pm

State of the Art Session

Lymph Node Resection in Primary and Relapsed Ovarian Cancer?
C. Fotopoulou

01:20 – 02:20 pm

Satellite Symposium with kind support of Immunogen

ADCs in Platinum-resistant Ovarian Cancer
Chair: J. Sehouli

  • Antibody-Drug Conjugates (ADCs) – A New Class in Ovarian Cancer
    P. Harter
  • ADC Experience and Management: What have We Learnt? – 1 Year of ADC Experience
    K. Moore
  • How to Prepare your Clinic for ADCs: Treatment and Management
    G. Konecny
  • Panel Discussion and Q&A
    J. Sehouli + Speakers
02:20 – 03:00 pm


HRD-related Therapies: PRIMA vs. Paola vs. Athena vs. Ov-43 vs. Duo-O and More…
What is the Best Strategy?

  • Mayo Perspective: A. Wahner Hendrickson
  • Charité Perspective: E. I. Braicu

Expert Panel: Can We Define a Global Consensus?
B. Monk, K. Moore, A. Wahner Hendrickson, K. Fujiwara, P. Harter, I. Ray-Coquard + Chairs

03:00 – 03:25 pm

Educational Session

Prehabilitation in Ovarian Cancer

  • Mayo Perspective: A. Kumar
  • Charité Perspective: The Charité Priming Concept for Gynecological Cancers: J. Sehouli

Enhanced Recovery after Surgery (ERAS) (incl. Optimal Perioperative Pain Management)

  • Mayo Perspective: S. Dowdy
  • Charité Perspective: M. Lee

Best Supportive Care Only or Chemotherapy or a Specific Cancer Therapy?
A. Wahner Hendrickson

03:25 – 03:35 pm

Part III: Endometrial Cancer

icon berlin time webChairs: K. Pietzner, R. Chekerov, A. Mariani (Berlin)
Co-Chair: N. Concin (online)
03:35 – 03:55 pm

Presidential Lecture

Endometrial Cancer Management: Yesterday, Today, Tomorrow (incl. Targeted Therapies, ADCs)
N. Concin

03:55 – 04:55 pm

Satellite Symposium with kind support of GlaxoSmithKline

Management of Endometrial Cancer 2024 – From Clinical Study to Daily Routine
Chair: J. Sehouli

  • Welcome and Introduction
    J. Sehouli
  • Surgery, Value of Radiotherapy, Diagnosis
    K. Pietzner
  • Current Therapy Landscape, Patient’s Perspective, Management of Side Effects
    J. Sehouli
  • IO + Chemotherapy; Recent Study Data; Outlook
    M. R. Mirza
  • “The Berlin CMC Consensus”
    Statement of the speakers
  • Summary
    J. Sehouli
04:55 – 05:15 pm

Pro/Con Debate

FIGO Staging

  • PRO: G. Glaser, F. Fotopoulou
  • CON: M. Shahi, P. Ramirez
05:15 – 05:45 pm


  • Role of PARP Inhibitors in Endometrial Cancer
    J. Sehouli
  • What is the Best Therapy for Relapsed Endometrial Cancer? Chemotherapy Pretreated or Naïve?
    G. Choong
  • Options and Limits of HRD Diagnostic in Endometrial Cancer
    E. I. Braicu
05:45 – 06:15 pm

Panel Discussion

  • ENGOT-en9/Leap-001: Pembrolizumab and Lenvatinib in Endometrial Cancer
    C. Marth
  • Duo-E, Leap-001, NRG-18, RUBY, Garnet, KEYNOTE-158, KEYNOTE-775, SIENDO, PALEO and More… – How to Integrate the Recent Milestone Trials into Clinical Practice?
    M. R. Mirza, D. Lorusso, C. Marth, J. Weroha, J. Sehouli + Chairs

Part IV: Cervical Cancer

icon berlin time webChairs: M. Z. Muallem, E. Delarue, S. Dowdy (Berlin)
Co-Chair: S. Mahner (online)
06:15 – 06:35 pm

Presidential Lecture

Cervical Cancer Management: Yesterday, Today, Tomorrow – The Global Perspective
L. Chinula

06:35 – 07:20 pm


Revolution in Cervical Cancer Surgery? Radical Hysterectomy, Simple Hysterectomy, or Cone Biopsy in Early-stage Cervical Cancer
S. Mahner

Role of Neoadjuvant Chemotherapy in High-risk Cervical Cancer:
J. Ledermann

Surgery, Radiochemotherapy, or Incorporation of Immunotherapy in Primary Cervical Cancer?
D. Lorusso

07:20 – 07:40 pm

Panel Discussion

Insights of Charité Mayo Practise and How to Translate these Data into Clinical Routine?
M. Block, J. Sehouli, F. Mehrhof, P. Wimberger, R. Armbrust + Chairs

07:40 – 08:00 pm


Newest Options with ADCs in Relapsed Cervical Cancer
I. Vergote

Phase I Data and Immunotherapy
M. Block

08:00 pm

Closing Session

Presentation of the Three Best Posters
Closing Words and Farewell

08:10 pm

Berlin Cultural Highlight icon berlin cultural highlight

Berlin Cultural Highlight

Start: 08:10 pm (after the scientific program), Streamed at the conference platform


German-Moroccan Theater Actor, Film Actor And Musician with a

Musical Performance

exclusively for the CMC 2024

Online Poster Exhibition

Do not forget to visit the Online Poster Exhibition! Access at the conference platform.

Register (for free) at

Abstract Committee

K. Pietzner and C. Flethe, Department of Gynecology with Center for Oncological Surgery, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin (D)

Status: February 2024; may be subject to change

CMC Distilled Berlin